DESTINY-Breast01: Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2 positive metastatic breast cancer1

[embeddoc url=”https://www.medpedia.com.br/wp-content/uploads/2022/03/QuickIM_DESTINY-Breast03_ESMO_2021_Data_Summary_Card.pdf”]